Although the exact mechanism is unknown, studies in colon cancer models have shown that the overexpression of RKIP inhibits IL-6-, Jak-, or Src kinase-mediated phosphorylation of STAT3 known to be necessary for its activation [1,17] (Figure 1C). Here, IL6 is linked to malignant colon neoplasm.